Science Explorer Back to mapMap
Discussion
Company · Tampa · United States

TransGenex Nanobiotech (United States)

transgenex.comROR OpenAlex
Research works
6
▼ 65% vs 2018-21
Citations
333
59.4 per fractional work
Top-10% rate
15.7%
all institutions 10.0%
Open access
45%
world 40%
International
31%
world 18%
TransGenex Nanobiotech (United States)

Not ranked overall: TransGenex Nanobiotech (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does TransGenex Nanobiotech (United States) work in?

In all years, 45% of research at TransGenex Nanobiotech (United States) is in Life Sciences, 34% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (38%), Medicine (20%), Engineering (20%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 44.6% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 37.6% of its workMolecular Biology: 1 fractional works · 21.7% of its workCancer Research: 1 fractional works · 11.4% of its workCell Biology: 0 fractional works · 3.0% of its workBiotechnology: 0 fractional works · 1.4% of its workImmunology and Microbiology: 0 fractional works · 7.0% of its workImmunology: 0 fractional works · 3.0% of its workMicrobiology: 0 fractional works · 2.0% of its workVirology: 0 fractional works · 2.0% of its workPhysical Sciences: 2 fractional works · 33.7% of its workEngineering: 1 fractional works · 19.6% of its workBiomedical Engineering: 1 fractional works · 16.2% of its workElectrical and Electronic Engineering: 0 fractional works · 2.7% of its workMechanical Engineering: 0 fractional works · 0.7% of its workMaterials Science: 1 fractional works · 9.1% of its workMaterials Chemistry: 0 fractional works · 5.0% of its workBiomaterials: 0 fractional works · 3.9% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.4% of its workEnergy: 0 fractional works · 2.9% of its workRenewable Energy, Sustainability and the Environment: 0 fractional works · 2.9% of its workEnvironmental Science: 0 fractional works · 0.9% of its workWater Science and Technology: 0 fractional works · 0.9% of its workChemistry: 0 fractional works · 0.7% of its workInorganic Chemistry: 0 fractional works · 0.7% of its workChemical Engineering: 0 fractional works · 0.5% of its workBioengineering: 0 fractional works · 0.5% of its workHealth Sciences: 1 fractional works · 21.7% of its workMedicine: 1 fractional works · 19.8% of its workOncology: 1 fractional works · 10.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 4.1% of its workInfectious Diseases: 0 fractional works · 2.3% of its workEpidemiology: 0 fractional works · 1.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNursing: 0 fractional works · 2.0% of its workNutrition and Dietetics: 0 fractional works · 2.0% of its workALL ITS WORKTransGenexNanobiotech…6fractional works, all years
Life Sciences45%Physical Sciences34%Health Sciences22%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology237.6%
    2. Immunology and Microbiology07.0%
    1. Engineering119.6%
    2. Materials Science19.1%
    3. Energy02.9%
    4. Environmental Science00.9%
    5. Chemistry00.7%
    6. Chemical Engineering00.5%
    1. Medicine119.8%
    2. Nursing02.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.63× its world share, 0 worksBiochemistry, Geneti…Chemistry: 2.61× its world share, 0 worksChemistryEnergy: 16.97× its world share, 0 worksEnergyEngineering: 1.13× its world share, 0 worksEngineeringEnvironmental Science: 0.94× its world share, 0 worksEnvironmental ScienceMaterials Science: 5.08× its world share, 0 worksMaterials ScienceNursing: 22.28× its world share, 0 worksNursing1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 22.3×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Nursing22.28×0 works
  2. Energy16.97×0 works
  3. Biochemistry, Genetics and Molecular Biology5.63×0 works
  4. Materials Science5.08×0 works
  5. Chemistry2.61×0 works
  6. Engineering1.13×0 works
  7. Environmental Science0.94×0 works

What are the most cited papers from TransGenex Nanobiotech (United States)?

The most cited paper from TransGenex Nanobiotech (United States) is "Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene" (Weidong Zhang, Yang Hong, Xiaoyuan Kong et al., 2004), with 369 citations. Next come "Core–shell nanostructures: perspectives towards drug delivery applications" (227) and "Multifunctional magnetic nanoparticles for targeted delivery" (184).

Most cited papers
#PaperReleasedCitations
1 Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene Weidong Zhang, Yang Hong, Xiaoyuan Kong et al. · Nature Medicine 26 Dec 2004 369
2 Core–shell nanostructures: perspectives towards drug delivery applications Raj Kumar, Kunal Mondal, Pritam Kumar Panda et al. · Journal of Materials Chemistry B 2020 227
3 Multifunctional magnetic nanoparticles for targeted delivery Arun Babu Kumar, Prasanna K. Jena, Sumita Behera et al. · Nanomedicine Nanotechnology Biology and Medicine Open access 15 May 2009 184
4 Development of hyaluronic acid–Fe2O3 hybrid magnetic nanoparticles for targeted delivery of peptides Arun Babu Kumar, Bishwabhusan Sahoo, Alison J. Montpetit et al. · Nanomedicine Nanotechnology Biology and Medicine Jun 2007 98
5 Natriuretic Peptide Receptor A as a Novel Anticancer Target Xiaoyuan Kong, Xiaoqin Wang, Weidong Xu et al. · Cancer Research 2008 89
All 20 most cited papers, with filters and sorting

Which research topics does TransGenex Nanobiotech (United States) publish most on?

By volume in 2022-now: Protein Hydrolysis and Bioactive Peptides, Nanoparticle-Based Drug Delivery, Copper-based nanomaterials and applications and Advanced Photocatalysis Techniques.

Protein Hydrolysis and B…0Protein Hydrolysis and Bioactive Peptides: 0 fractional worksNanoparticle-Based Drug …0Nanoparticle-Based Drug Delivery: 0 fractional worksCopper-based nanomaterials and applications: 0 fractional worksAdvanced Photocatalysis …0Advanced Photocatalysis Techniques: 0 fractional worksTiO2 Photocatalysis and …0TiO2 Photocatalysis and Solar Cells: 0 fractional worksCancer Research and Trea…0Cancer Research and Treatments: 0 fractional worksNanoplatforms for cancer…0Nanoplatforms for cancer theranostics: 0 fractional worksMicrobial Metabolites in…0Microbial Metabolites in Food Biotechnology: 0 fractional worksGut microbiota and health0Gut microbiota and health: 0 fractional works
Molecular BiologyBiomaterialsMaterials ChemistryRenewable Energy, Sustainability and the Environment3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Protein Hydrolysis and Bioactive Peptides Molecular Biology 0 works
  2. 2 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  3. 3 Copper-based nanomaterials and applications Materials Chemistry 0 works
  4. 4 Advanced Photocatalysis Techniques Renewable Energy, Sustainability and the Environment 0 works
  5. 5 TiO2 Photocatalysis and Solar Cells Renewable Energy, Sustainability and the Environment 0 works
  6. 6 Cancer Research and Treatments Biotechnology 0 works
  7. 7 Nanoplatforms for cancer theranostics Biomedical Engineering 0 works
  8. 8 Microbial Metabolites in Food Biotechnology Nutrition and Dietetics 0 works
  9. 9 Gut microbiota and health Molecular Biology 0 works
  10. 10 Environmental remediation with nanomaterials Biomedical Engineering 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.3%not open54.7%

World: 40% of research is openly available.

with international co-authors31.1%domestic only68.9%

World: 18% is written across borders.

How has TransGenex Nanobiotech (United States)'s research output changed?

Output in 2022-2025 was 65% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is TransGenex Nanobiotech (United States) as a percentage of every work published that year, 0.0000063% in 2022.

still counting0.000010%0.000020%0.000030%TransGenex Nanobiotech (United States)0.0000029% in 202520102020

Fractional works of TransGenex Nanobiotech (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Tampa

All research institutions in Tampa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about TransGenex Nanobiotech (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.